Studies have reported that LINC00665 played a vital role in breast cancer progression, and LINC00665 Knockdown inhibited breast cancer cells proliferation, migration, and invasion but promoted apoptosis (Ji et al., 2020; Lv et al., 2020; Zhou et al., 2020; Qi et al., 2021). Here, LINC00665 is linked to breast carcinoma.